08.37 Fri 17 Jul 2026
AtaiBeckley Inc. CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss topline results from the company’s exploratory, double-blind, placebo-controlled Phase 2a trial evaluating EMP-01 in adults with Social Anxiety Disorder (SAD).The first-in-patient study met its primary safety...